The expression of transforming growth factor-β1 and α-smooth muscle actin is increased in the human myxomatous valve

Korean Journal of Pathology

Volumn 43, Issue 2, 2009, Pages 152-156

  Park, Jeong Hwan ^a   Youn, Ho Joong ^a   Yoon, Jung Sook ^a   Park, Chul Soo ^a   Oh, Soo Sung ^a   Chung, Woo Baek ^a   Chung, Jong Won ^a   Choi, Yun Seok ^a   Lee, Dong Hyun ^a   Oh, Yong Seog ^a   Chung, Wook Sung ^a   Hong, Soon Jo ^a   Lee, Youn Soo ^a   Sim, Sung Bo ^a   Lee, Sun Hee ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Alpha smooth muscle actin; Myxomatous valve; Transforming growth factor beta1

Indexed keywords

EID: 70349495620     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2009.43.2.152     Document Type: Article

References (20)

1. Rahimtoola SH, Frye RL. Valvular heart disease. Circulation 2000; 102: 24-33.
2. Mills WR, Barber JE, Ratliff NB, Cosgrove DM 3rd, Vesely I, Griffin BP. Biomechanical and echocardiographic characterization of flail mitral leaflet due to myxomatous disease: further evidence for early surgical intervention. Am Heart J 2004; 148: 144-50.
3. Rabkin E, Aikawa M, Stone JR, Fukumoto Y, Libby P, Schoen FJ. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 2001; 104: 2525-32.
4. Rabkin-Aikawa E, Farber M, Aikawa M, Schoen FJ. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J Heart Valve Dis 2004; 13: 841-7.
5. Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA. Valvular myofibroblast activation by transforming growth factor-β: implications for pathological extracellular matrix remodeling in heart valve disease. Circulation Research 2004; 95: 253-60.
6. Cushing MC, Liao JT, Anseth KS. Activation of valvular interstitial cells in mediated by transforming growth factor-beta 1 interactions with matrix molecules. Matrix Biology 2005; 24: 428-37.
7. Barber JE, Kasper FK, Ratliff NB, Cosgrove DM, Griffin BP, Vesely I. Mechanical properties of myxomatous mitral valves. J Thorac Cardiovasc Surg 2001; 122: 955-62.
8. Gupta V, Grande-Allen KJ. Effects of static and cyclic loading in regulating extracellular matrix synthesis by cardiovascular cells. Cardiovasc Res 2006; 72: 375-83.
9. Grande-Allen KJ, Griffin BP, Ratliff NB, Cosgrove DM, Vesely I. Gly-cosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations. J Am Coll Cardiol 2003; 42: 271-7.
10. Tamura K, Fukuda Y, Ishizaki M, Masuda Y, Yamanaka N, Ferrans VJ. Abnormalities in elastic fibers and other connective-tissue components of floppy mitral valve. Am Heart J 1995; 129: 1149-58.
11. Grande-Allen KJ, Griffin BP, Calabro A, Ratliff NB, Cosgrove DM 3rd, Vesely I. Myxomatous mitral valve chordae. II: selective elevation of glycosaminoglycan content. J Heart Valve Dis 2001; 10: 325-32.
12. Akhtar S, Meek KM, James V. Ultrastructure abnormalities in proteoglycans, collagen fibrils, and elastic fibers in normal and myxomatous mitral valve chordae tendineae. Cardiovasc Pathol 1999; 8: 191-201.
13. Baker PB, Bansal G, Boudoulas H, Kolibash AJ, Kilman J, Wooley CF. Floppy mitral valve chordae tendineae: histopathologic alterations. Hum Pathol 1988; 19: 507-12.
14. Tamura K, Fukuda Y, Ishizaki M, Masuda Y, Yamanaka N, Ferrans VJ. Abnormalities in elastic fibers and other connective-tissue components of floppy mitral valve. Am Heart J 1995; 129: 1149-58.
15. Taylor PM, Batten P, Brand NJ, Thomas PS, Yacoub MH. The cardiac valve interstitial cell. Int J Biochem Cell Biol 2003; 35: 113-8.
16. Mulholland D, Gotlieb AI. Cardiac valve interstitial cells: regulator of valve structure and function. Cardiovasc Pathol 1997; 6: 167-74.
17. Mulholland DL, Gotlieb AI. Cell biology of valvular interstitial cells. Can J Cardiol 1996; 12: 231-6.
18. Malmström J, Lindberg H, Lindberg C, et al. Transforming growth factor-beta 1 specifically induce proteins involved in the myofibroblast contractile apparatus. Mol Cell Proteomics 2004; 3: 466-77.
19. Khan R, Sheppard R. Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology 2006; 118: 10-24.
20. Ng CM, Cheng A, Myers LA, et al. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 2004; 114: 1543-6.